Celularity Inc. (CELU)
Nasdaq: CELU · Pharmaceutical Preparations · Florham Park, NJ · filing with the SEC since 2018
Filings
372 filings since 2017 beside 191 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026Due next and emerging growth company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Nov 10, 2026.
Filings a yearinsider forms included
291314910271558656
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 18 times in the last 36 months, the newest Sep 29, 2026.Listing warning from its exchange (8-K item 3.01): 9 times in the last 36 months, the newest Jul 29, 2026.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Aug 5, 2024.SEC letters: 7 in the last 36 months, the newest Jan 5, 2026.A late-filing notice, Form NT 10-Q, filed Aug 14, 2026.A late-filing notice, Form NT 10-Q, filed May 15, 2026.A late-filing notice, Form NT 10-K, filed Mar 31, 2026.A late-filing notice, Form NT 10-K, filed Mar 31, 2025.A late-filing notice, Form NT 10-Q, filed Nov 15, 2024.A late-filing notice, Form NT 10-Q, filed Aug 16, 2024.A late-filing notice, Form NT 10-Q, filed May 15, 2024.A late-filing notice, Form NT 10-K, filed Apr 1, 2024.A late-filing notice, Form NT 10-Q, filed Nov 14, 2023.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Sep 28, 2026
8-K items 1.01, 2.03, 3.02, 5.02, 9.01
Major agreement signed; New debt or obligation taken on; Shares sold without registration; Officer or director change · Current report
Sep 18, 2026
Jun 30, 2026
8-K items 1.01, 2.03, 5.02, 9.01
Major agreement signed; New debt or obligation taken on; Officer or director change · Current report
Jun 26, 2026
Jun 3, 2026
8-K items 5.02, 7.01, 9.01
Officer or director change; Investor disclosure (Regulation FD) · Current report
May 29, 2026
May 28, 2026
8-K items 1.01, 2.03, 9.01
Major agreement signed; New debt or obligation taken on · Current report
May 21, 2026
Apr 21, 2026
8-K items 1.01, 2.03, 3.03, 5.02, 8.01, 9.01
Major agreement signed; New debt or obligation taken on; Change to shareholders' rights; Officer or director change; Other event · Current report
Apr 9, 2026
Mar 10, 2026
8-K items 1.01, 8.01, 9.01
Major agreement signed; Other event · Current report
Mar 6, 2026
40 of 372 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.